92 related articles for article (PubMed ID: 23548582)
21. Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors.
Tebbe JJ; Mronga S; Schäfer MK; Rüter J; Kobelt P; Mönnikes H
Am J Physiol Gastrointest Liver Physiol; 2003 Dec; 285(6):G1075-83. PubMed ID: 12855401
[TBL] [Abstract][Full Text] [Related]
22. BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties.
Doods HN; Wieland HA; Engel W; Eberlein W; Willim KD; Entzeroth M; Wienen W; Rudolf K
Regul Pept; 1996 Aug; 65(1):71-7. PubMed ID: 8876038
[TBL] [Abstract][Full Text] [Related]
23. Neuropeptide Y Y1 receptor antagonist (BIBP 3226) attenuates stress evoked tachycardia in conscious spontaneously hypertensive rats.
Zhang W; Lundberg JM; Thorén P
Cardiovasc Drugs Ther; 1997 Dec; 11(6):801-6. PubMed ID: 9512876
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Herring N; Lokale MN; Danson EJ; Heaton DA; Paterson DJ
J Mol Cell Cardiol; 2008 Mar; 44(3):477-85. PubMed ID: 17996892
[TBL] [Abstract][Full Text] [Related]
25. Increase in neuropeptide Y activity impairs social behaviour in association with glutamatergic dysregulation in diabetic mice.
Ueda D; Yonemochi N; Kamata T; Shibasaki M; Kamei J; Waddington JL; Ikeda H
Br J Pharmacol; 2021 Feb; 178(3):726-740. PubMed ID: 33197050
[TBL] [Abstract][Full Text] [Related]
26. Contribution of Baroreflex Afferent Pathway to NPY-Mediated Regulation of Blood Pressure in Rats.
Liu Y; Zhao SY; Feng Y; Sun J; Lu XL; Yan QX; Li Y; Liu Z; Wang LQ; Sun X; Li S; Qiao GF; Li BY
Neurosci Bull; 2020 Apr; 36(4):396-406. PubMed ID: 31659606
[TBL] [Abstract][Full Text] [Related]
27. The effect of a neuropeptide Y antagonist, BIBP 3226, on short-term arterial pressure control in conscious unrestrained rats with congestive heart failure.
Zhang W; Lundberg JM; Thorén P
Life Sci; 1999; 65(17):1839-44. PubMed ID: 10576563
[TBL] [Abstract][Full Text] [Related]
28. Impaired regulation function in cardiovascular neurons of nucleus tractus solitarii in streptozotocin-induced diabetic rats.
Chen HY; Wu JS; Chen JJ; Cheng JT
Neurosci Lett; 2008 Jan; 431(2):161-6. PubMed ID: 18162316
[TBL] [Abstract][Full Text] [Related]
29. Acceleration of development of diabetic cataract by hyperlipidemia and low high-density lipoprotein in rats.
Tsutsumi K; Inoue Y; Yoshida C
Biol Pharm Bull; 1999 Jan; 22(1):37-41. PubMed ID: 9989659
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
31. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Rimondini R; Thorsell A; Heilig M
Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
[TBL] [Abstract][Full Text] [Related]
33. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure.
Callanan EY; Lee EW; Tilan JU; Winaver J; Haramati A; Mulroney SE; Zukowska Z
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1811-7. PubMed ID: 17804485
[TBL] [Abstract][Full Text] [Related]
34. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
35. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
[TBL] [Abstract][Full Text] [Related]
36. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
[TBL] [Abstract][Full Text] [Related]
37. Restraint stress potentiates neuropeptide Y-mediated impairment on spatial memory in rats.
Soares ES; Vanz F; Linartevichi VF; Cimarosti H; de Lima TCM
Behav Brain Res; 2022 Feb; 419():113705. PubMed ID: 34871704
[TBL] [Abstract][Full Text] [Related]
38. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration.
Schroeder JP; Olive F; Koenig H; Hodge CW
Alcohol Clin Exp Res; 2003 Dec; 27(12):1884-91. PubMed ID: 14691375
[TBL] [Abstract][Full Text] [Related]
39. Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors.
Zukowska-Grojec Z; Dayao EK; Karwatowska-Prokopczuk E; Hauser GJ; Doods HN
Am J Physiol; 1996 Feb; 270(2 Pt 2):H796-800. PubMed ID: 8779858
[TBL] [Abstract][Full Text] [Related]
40. Influence of fluvastatin on cardiac function and baroreflex sensitivity in diabetic rats.
Xie F; Sun C; Sun LH; Li JY; Chen X; Che H; Lu GY; Yang BF; Ai J
Acta Pharmacol Sin; 2011 Mar; 32(3):321-8. PubMed ID: 21372824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
